Absorption of Iron From Stabilized Lactoferrin: A Study in Women With Iron Deficiency
NCT07394972 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2026-02-12
Summary
Lactoferrin (LF) is a natural iron-binding protein found in milk. It exists either in an iron-free state (apo-LF) or bound to iron (holo-LF). Whether LF binds iron to facilitate its absorption and/or to sequester iron from potential enteropathogens remains uncertain. However, while LF is a promising tool for treating iron deficiency, it is sensitive to heat during food processing and to the acidic environment of the human stomach. This degradation often causes LF to lose its functional properties before it can promote iron absorption effectively.
This study aims to evaluate whether encapsulating apo-LF (either alone or in combination with iron) can protect LF from digestion and enhance iron absorption. Using a randomized, crossover design, different encapsulation methods will be compared to determine which results in the highest iron absorption in women with iron deficiency.
All test compounds will be labeled with stable iron isotopes. Participants will consume the labeled compounds with a test meal or water in a randomized order, allowing for within subject comparisons. Fractional iron absorption will be measured 17 days after administration via the incorporation of labeled iron into red blood cells.
Conditions
- Iron Deficiency (Without Anemia)
Interventions
- OTHER
-
FeSO4 + meal-matrix
Maize porridge with labelled ferrous sulfate (58Fe)
- OTHER
-
FeSO4 + native LF + meal-matrix
Maize porridge with labelled ferrous sulfate (58Fe) and lactoferrin
- OTHER
-
FeSO4 + NaCas-LF + meal-matrix
Maize porridge with labelled ferrous sulfate (57Fe) and in sodium caseinate encapsulated lactoferrin
- OTHER
-
NaCas-LF-Fe + meal-matrix
Maize porridge with sodium caseinate-lactoferrin-Fe (intrinsically labeled with iron isotope 54)
- OTHER
-
FeSO4 + LMP-LF + meal-matrix
Maize porridge with labelled ferrous sulfate (54Fe) and low methoxy pectin lactoferrin
- OTHER
-
LMP-LF-Fe + meal-matrix
Maize porridge with low methoxy pectin-lactoferrin-Fe (intrinsically labelled with iron isotope 57)
- OTHER
-
NaCas-LF-Fe + water
Water with sodium caseinate-lactoferrin-Fe (intrinsically labelled with iron isotope 54Fe)
- OTHER
-
LMP-LF-Fe + water
Water with low methoxy pectin-lactoferrin-Fe (intrinsically labelled with iron isotope 57Fe)
- OTHER
-
FeSO4 + water
Water with ferrous sulfate (labelled with iron isotope 58Fe)
Sponsors & Collaborators
-
Nicole Stoffel
lead OTHER
Principal Investigators
-
Nicole Ursula Stoffel, Prof. · ETH Zurich
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-02-17
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Iron Interventions and Non-transferrin-bound Iron (NTBI) in Women
NCT01404533 ·Status: COMPLETED ·Phase: NA
-
Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy
NCT01588665 ·Status: COMPLETED
-
Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors
NCT00689793 ·Status: COMPLETED ·Phase: PHASE4
-
Lactoferrin With Ferrous Gluconate Versus Ferrous Gluconate in Treatment of Iron Deficiency Anemia During Pregnancy
NCT06252103 ·Status: COMPLETED ·Phase: PHASE4
-
Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy
NCT03484845 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Lactoferrin in Heart Failure Patients
NCT06427200 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load
NCT02831712 ·Status: UNKNOWN ·Phase: NA
-
Iron Absorption From Tef-injera in Women of Reproductive Age
NCT01687062 ·Status: COMPLETED ·Phase: NA
-
Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women
NCT06851130 ·Status: RECRUITING ·Phase: NA
-
Iron Long-Term Labelling Study Benin
NCT02979080 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects
NCT04778072 ·Status: UNKNOWN ·Phase: NA
-
A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia
NCT00399191 ·Status: COMPLETED ·Phase: PHASE1
-
Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
NCT03873584 ·Status: WITHDRAWN
-
Clinical Importance of Treating Iron Overload in Sickle Cell Disease
NCT00981370 ·Status: TERMINATED ·Phase: PHASE3
-
Lactoferrin Versus Ferrous Sulphate for the Treatment of Iron Deficiency Anemia During Pregnancy
NCT03456258 ·Status: COMPLETED ·Phase: NA
-
Lactoferrin Versus Ferrous Sulfate in Iron-deficiency During Pregnancy
NCT03759353 ·Status: COMPLETED ·Phase: PHASE2
-
Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia
NCT01757119 ·Status: COMPLETED ·Phase: PHASE1
-
the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis
NCT03748043 ·Status: UNKNOWN ·Phase: PHASE4
-
The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias
NCT01409967 ·Status: COMPLETED
-
High-Tc Susceptometer to Monitor Transfusional Iron Overload
NCT01241357 ·Status: COMPLETED
-
Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency
NCT04139265 ·Status: COMPLETED
-
Absorption of Heme and Non-Heme Iron in Pregnant and Non-pregnant Women and Mechanisms of Fetal Iron Transfer
NCT01019096 ·Status: COMPLETED
-
Iron Absorption and Variations of Iron Status, Hepcidin, Inflammation and Sex Hormones During the Menstrual Cycle
NCT05580783 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia
NCT03683810 ·Status: UNKNOWN ·Phase: PHASE1
-
Effectiveness of Low-dose Iron Treatment in Non-anaemic Iron-deficient Women
NCT04636060 ·Status: COMPLETED ·Phase: NA